Login

Financial Snapshot

Revenue
TTM
$6.910M
Gross Margin
TTM
-59.57%
Net Income
TTM
$26.55M
Current Assets
2025 Q1
$6.410M
Current Liabilities
2025 Q1
$15.35M
Current Ratio
2025 Q1
41.76%
Total Assets
2025 Q1
$411.0M
Total Liabilities
2025 Q1
$15.00M
Book Value
2025 Q1
396.0M
Cash
Last 4 Quarters
N/A
P/E
TTM
20.46
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $543.09 Million

About abrdn Life Sciences Investors

abrdn Life Sciences Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in equity and related securities of the United States and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in life sciences (including biotechnology, pharmaceuticals, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices, supplies and other healthcare-related sub-sectors), agriculture and environmental management (Life Sciences Companies). The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.

Industry: UNKNOWN

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support